Want to see AU:MX1 full AI Analyst Report?
MX1 Stock Chart & Stats
AU$0.03
AU$0.00(0.00%)
At close: 4:00 PM EDT
AU$0.03
AU$0.00(0.00%)
Day’s Range― - ―
52-Week RangeAU$0.03 - AU$0.12
Previous CloseN/A
Volume167.40K
Average Volume (3M)189.28K
Market Cap
AU$20.94M
Enterprise ValueAU$68.28
Total Cash (Recent Filing)AU$4.90M
Total Debt (Recent Filing)AU$5.13M
Price to Earnings (P/E)―
Beta0.69
Next Earnings
Aug 27, 2026Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding748,032,960
10 Day Avg. Volume131,613
30 Day Avg. Volume189,275
Financial Highlights & Ratios
PEG Ratio-0.09
Price to Book (P/B)3.96
Price to Sales (P/S)2.29
P/FCF Ratio-3.44
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$0.08Price Target Upside166.67% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)>-0.01
Revenue Forecast (FY)AU$28.90M
Bulls Say, Bears Say
Bulls Say
Proprietary X-ray Tube TechnologyMicro-X's proprietary cold cathode X-ray tube is a durable competitive asset: it enables smaller, lighter and lower-power products suited to mobile medical and security markets. That IP and product differentiation support long-term OEM partnerships, product premiuming and higher entry barriers.
High Gross Profit MarginA 79% gross margin indicates strong unit economics from the core technology. If the company can scale sales and control operating costs, these margins provide a runway to absorb R&D and SG&A, improving the odds of converting tech strength into sustained operating profitability over time.
Diverse Revenue StreamsMultiple monetization paths—product sales, OEM supply/licensing, contract development and service—reduce customer concentration and offer recurring and royalty-like income potential. This diversification supports steadier revenue as product rollouts and partnerships mature.
Bears Say
Negative Operating And Free Cash FlowPersistent negative operating and free cash flows constrain the firm's ability to self-fund commercialization and scale. Over a 2-6 month horizon this increases reliance on external financing, raising execution risk and potentially delaying product launches or customer support investments.
Declining Revenue And Ongoing LossesA recent revenue decline and continued negative margins suggest weak commercial traction or pricing/volume issues. This undermines the company's ability to leverage its high gross margins and increases the probability of prolonged cash burn, hindering sustainable margin recovery.
Rising Leverage And Negative ROEElevated debt-to-equity and negative ROE indicate a weaker balance sheet and reduced financial flexibility. Increased leverage raises interest and refinancing risk, limiting the company's ability to invest in growth initiatives or weather revenue variability without dilutive or costly financing.
Micro-X Ltd. News
MX1 FAQ
What was Micro-X Ltd.’s price range in the past 12 months?
Micro-X Ltd. lowest share price was AU$0.03 and its highest was AU$0.12 in the past 12 months.
What is Micro-X Ltd.’s market cap?
Micro-X Ltd.’s market cap is AU$20.94M.
When is Micro-X Ltd.’s upcoming earnings report date?
Micro-X Ltd.’s upcoming earnings report date is Aug 27, 2026 which is in 15 days.
How were Micro-X Ltd.’s earnings last quarter?
Micro-X Ltd. released its earnings results on Feb 26, 2026. The company reported -AU$0.01 earnings per share for the quarter, missing the consensus estimate of -AU$0.006 by -AU$0.004.
Is Micro-X Ltd. overvalued?
According to Wall Street analysts Micro-X Ltd.’s price is currently Undervalued.
Does Micro-X Ltd. pay dividends?
Micro-X Ltd. does not currently pay dividends.
What is Micro-X Ltd.’s EPS estimate?
Micro-X Ltd.’s EPS estimate is 0.
How many shares outstanding does Micro-X Ltd. have?
Micro-X Ltd. has 748,032,960 shares outstanding.
What happened to Micro-X Ltd.’s price movement after its last earnings report?
Micro-X Ltd. reported an EPS of -AU$0.01 in its last earnings report, missing expectations of -AU$0.006. Following the earnings report the stock price went up 15.385%.
Which hedge fund is a major shareholder of Micro-X Ltd.?
Currently, no hedge funds are holding shares in AU:MX1
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Micro-X Ltd. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
AU$0.08 (166.67% Upside)
AU$0.08 (166.67% Upside)
Blogger Sentiment
Bullish
AU:MX1 Sentiment 100%
Sector Average ―
Sector Average ―
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
3.40%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-12.76%
Trailing 12-Months
Company Description
Micro-X Ltd.
Micro-X Limited designs, develops, manufactures, and commercializes imaging products for healthcare, defense, and security markets through cold cathode X-ray technology. The company provides carbon nanotube-based X-ray products, including core X-ray tube and high-voltage generator components. It also provides Rover Plus for medical performance in a mobile system; Head CT, a standard ambulance or retrieval aircraft for stroke; Checkpoints, a modular passenger self-screening checkpoint for airports; Baggage scanner, a CT baggage scanner for passenger self-screening checkpoints; Argus, a wide-area scattered projection backscatter and miniaturized high-voltage generator; and space imaging solutions. The company operates in Australia, the United States, the Asia-Pacific, Europe, the Middle East, and Africa. Micro-X Limited was incorporated in 2011 and is based in Tonsley, Australia.
MX1 Stock 12 Month Forecast
Average Price Target
AU$0.08
▲(166.67% Upside)
Technical Analysis
Compumedics Limited
―
Cyclopharm Limited
―
EMvision Medical Devices Ltd.
―
4DMedical Ltd
―
Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh
―